Skip to main content
. 2021 Oct 1;11:755814. doi: 10.3389/fonc.2021.755814

Figure 5.

Figure 5

Cell division cycle associated 2 (CDCA2) was associated with hepatocellular carcinoma (HCC) prognosis. (A–F) In The Cancer Genome Atlas (TCGA) cases, the impact of TNM stage and CDCA2 on the prognosis of all HCC cases, early HCC cases (TNM stage I/II), and mid- to late-stage HCC cases (TNM stage III/IV) was analyzed by Kaplan-Meier (KM) survival. (G) Forest plot illustrated the hazard ratio (HR) values of CDCA2 and TNM stage by multivariate Cox regression analysis. (H) The nomogram of prognostic 1-, 3-, and 5-year survival rates for HCC was constructed based on CDCA2 expression values [log2 (norm count + 1)] and TNM stage. (I) Receiver operating characteristic (ROC) curve analysis of predictive efficacy of the nomogram model. (J, K) Comparison of mRNA levels and survival analysis of CDCA2 in HCC and paraneoplastic samples originating from Japan in International Cancer Genome Consortium (ICGC) database. ***p < 0.001.